
    
      Patients will be prescribed a fixed dose combination of Ciprofloxacin and Celecoxib to be
      taken twice daily, and will be monitored for safety and tolerability. Additionally, routine
      progression measures will be assessed, as well as change in serum pNFH.
    
  